Activated CD26-high immune cells and CD26-negative immune cells and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11963980
APP PUB NO 20190247431A1
SERIAL NO

16095828

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods for the production of activated CD26high T cells by co-stimulation with inducible coactivator (ICOS). Further provided are methods for treatment of cancer by administration of the of activated CD26high T cells as an adoptive T cell therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bailey, Stefanie R Charleston, US 1 0
Nelson, Michelle H Charleston, US 5 241
Paulos, Chrystal M Charleston, US 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 23, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00